Next Article in Journal
SARS-CoV-2 Variants of Concern and Variations within Their Genome Architecture: Does Nucleotide Distribution and Mutation Rate Alter the Functionality and Evolution of the Virus?
Next Article in Special Issue
A Retrospective Study of Viral Molecular Prevalences in Cats in Southern Italy (Campania Region)
Previous Article in Journal
Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies
Previous Article in Special Issue
Canine Coronavirus Activates Aryl Hydrocarbon Receptor during In Vitro Infection
 
 
Article
Peer-Review Record

Seroprevalence of SARS-CoV-2 in 1186 Equids Presented to a Veterinary Medical Teaching Hospital in California from 2020 to 2022

Viruses 2022, 14(11), 2497; https://doi.org/10.3390/v14112497
by Kaila Lawton 1, Stefan M. Keller 2, Samantha Barnum 1, Christina Arredondo-Lopez 2, Kennedy Spann 1 and Nicola Pusterla 1,*
Reviewer 1: Anonymous
Reviewer 2:
Viruses 2022, 14(11), 2497; https://doi.org/10.3390/v14112497
Submission received: 26 October 2022 / Revised: 8 November 2022 / Accepted: 9 November 2022 / Published: 11 November 2022
(This article belongs to the Special Issue Enteric and Respiratory Viruses in Animals 3.0)

Round 1

Reviewer 1 Report

Dr. Lawton and colleagues describe a serologic study on SARS-CoV-2 in horses and associated risk factors in this manuscript.

I found this study to be very valuable because it satisfies the need for continued SARS-CoV-2 surveillance in domestic (and wild) animals for both one health and animal health objectives.

The sample size was adequate to allow for the generation of interesting hypotheses regarding the determinants connected to the seroprevalence of SARS-CoV-2.
The limitations of the study are also acknowledged correctly.

Just two minor observations for the authors:

1) I advise citing more recent in silico studies on horse ACE2 in addition to recent publications to highlight the growing body of knowledge about animal hosts.
2) I wouldn't generalize about seasons being a risk factor in such a way.
In fact, if I correctly understand the 2021 breaks, only 2020 samples were taken throughout each of the four seasons, and the sampling was completed in March 2022.
The greater number of seropositives in spring 2022, however, is still intriguing and emphasizes the significance of researching the potential expansion of the viral host range.

Thanks for this study

Best regards,

 

Author Response

Reviewer 1

1) I advise citing more recent in silico studies on horse ACE2 in addition to recent publications to highlight the growing body of knowledge about animal hosts.

The investigators have added recent in silico studies on horse ACE-2.


2) I wouldn't generalize about seasons being a risk factor in such a way.
In fact, if I correctly understand the 2021 breaks, only 2020 samples were taken throughout each of the four seasons, and the sampling was completed in March 2022. The greater number of seropositives in spring 2022, however, is still intriguing and emphasizes the significance of researching the potential expansion of the viral host range.

The investigators agree with reviewer that the greater number of seropositive horses detected in the spring time may relate to a possible expansion of the viral host range. A comment was added in the discussion.

Reviewer 2 Report

This is a nice, neat, well-written study about the role domestic horses play in SARS-CoV-2 circulation. I have just a few comments:

Methods: As the ELISA methods are almost identical to those described in Lawton et al. 2022 (ref. 7 in this manuscript) it would be appropriate to reduce this section considerably by just stating 'as described in Lawton et al.' and then to note any differences.

Results: It is stated that more samples were submitted in winter. Is it worth speculating why this might be?

Results: As most human infections occur in winter & spring, but statistically more samples from horses tested positive in spring, could this reflect a time-lag related to horses acquiring their infections from humans?  

Discussion - line 196: change to '...more common for the elderly...'

Conclusion - line 250: add '...paralleled the seasonal peak of COVID-19 in human populations.' 

Author Response

Reviewer 2

1) Methods: As the ELISA methods are almost identical to those described in Lawton et al. 2022 (ref. 7 in this manuscript) it would be appropriate to reduce this section considerably by just stating 'as described in Lawton et al.' and then to note any differences.

As suggested by the reviewer, the method has been shortened and referred to Lawton et al., 2022.

2) Results: It is stated that more samples were submitted in winter. Is it worth speculating why this might be?

Although more samples were collected/submitted during the winter months, the difference was not significant.

3) Results: As most human infections occur in winter & spring, but statistically more samples from horses tested positive in spring, could this reflect a time-lag related to horses acquiring their infections from humans? 

This is an interesting observation, although we are missing the information pertaining to the COVID-19 status of owners and care takers of the horses. Further, seroconversion observed in a handful of study horses took as little as 13 days in one horse.

4) Discussion - line 196: change to '...more common for the elderly...'

The sentence has been changed.

5) Conclusion - line 250: add '...paralleled the seasonal peak of COVID-19 in human populations.' 

The sentence has been changed.

Back to TopTop